Illumina partners with Pathogenica; Covidien kicks off balloon studies;

@FierceMedDev: Popular yesterday: For J&J, no device growth without Synthes. Article | Follow @FierceMedDev

 @MarkHFierce: The device tax has already cost the industry $1 billion. Editor's corner | Follow @MarkHFierce

@DamianFierce: Will all that M&A help Abbott turn its medical device sales around? More | Follow @DamianFierce

> Illumina ($ILMN) has inked a deal with Boston's Pathogenica to co-market the company's HAI BioDetection kit in Asia. More

> Covidien ($COV) has launch two global trials to evaluate its Stellarex drug-coated balloon, designed to treat peripheral artery disease. Item

> In a blog post, two FDA medical device ombudsmen explain how the agency handles complaints and disputes between the FDA and the industry it regulates. Story

> RTI Biologics has secured a $50 million private placement from Water Street Healthcare Partners, cash that will fund its $130 million buyout of Pioneer Surgical Technologies. News

> Ceterix Orthopaedics has launched its NovoStitch technology in the U.S., following a $19.5 million funding round in January. Article

> Massachusetts' Cognoptix has developed an eye test it says can detect beta amyloid deposits to identify Alzheimer's disease patients. Report

Biotech News

@FierceBiotech: Popular: Is this the NIH Francis Collins wanted to create? Editor's corner | Follow @FierceBiotech

 @JohnCFierce: GSK China official: We inflated conference costs, handed out bribes, pocketed cash and upped drug prices. More | Follow @JohnCFierce

@RyanMFierce: Bioinformatics buy bolsters Life's diagnostics pact with Merck Serono. Report | Follow @RyanMFierce

 @EmilyMFierce: Animal studies produce many false positives. More | Follow @EmilyMFierce

> Buzz: Pfizer prowls Onyx auction block as bidding looms. Report

> Sequella scouts $38M round after nabbing Pfizer antibiotic. Article

> Lundbeck, Otsuka tout improved cognition in mid-stage Alzheimer's study. More

Pharma News

@FiercePharma: More tit-for-tat in Vivus proxy fight: FMC sues over meeting delay. $VVUS didn't like scoreboard, says Colin. Story | Follow @FiercePharma

 @EricPFierce: FDA says Cispharma didn't do enough to make sure blood tissue didn't get into drugs when worker injured. Article | Follow @EricPFierce

 @CarlyHFierce: NICE nixes Pfizer's CML drug Bosulif. Article | Follow @CarlyHFierce

> Novartis ex-chair Vasella nets new $5.2M exit package. Story

> Teva reveals CEO pay secret: Levin collected $4.1M in 2012. Article

Drug Delivery News

 @MichaelGFierce: Rexahn snags nanotech platform for cancer drug delivery. Article | Follow @MichaelGFierce

> CalTech team combines two breast cancer drugs using nanoparticles. Report

> Math models tailor drug delivery using patient DNA. Story

> Melbourne team concocts self-assembling, nanoengineered drug delivery tech. Article

> York students eye crowdfunding for nanoparticle cancer patch treatment work. Item

> Oramed raising $4.6M for oral insulin trial. News